These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36777876)

  • 1. Long Non-coding RNAs: Pivotal Epigenetic Regulators in Diabetic Retinopathy.
    Song Z; He C; Wen J; Yang J; Chen P
    Curr Genomics; 2022 Aug; 23(4):246-261. PubMed ID: 36777876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network.
    Biswas S; Sarabusky M; Chakrabarti S
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31337130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs: Proverbial Genomic "Junk" or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?
    Biswas S; Thomas AA; Chakrabarti S
    Front Cardiovasc Med; 2018; 5():28. PubMed ID: 29670886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.
    Gong Q; Su G
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease.
    Shelke V; Kale A; Sankrityayan H; Anders HJ; Gaikwad AB
    Arch Physiol Biochem; 2024 Apr; 130(2):230-241. PubMed ID: 34986074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of lncRNAs in diabetic retinopathy.
    Huang Q; Li J
    Eur J Ophthalmol; 2021 Jul; 31(4):1606-1617. PubMed ID: 33176497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.
    Smit-McBride Z; Morse LS
    Ann Transl Med; 2021 Aug; 9(15):1280. PubMed ID: 34532417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
    Cataldi S; Tramontano M; Costa V; Aprile M; Ciccodicola A
    Antioxidants (Basel); 2022 Oct; 11(10):. PubMed ID: 36290744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
    Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
    Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface.
    Liu DD; Zhang CY; Zhang JT; Gu LM; Xu GT; Zhang JF
    Neural Regen Res; 2023 Jul; 18(7):1441-1449. PubMed ID: 36571340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Long Non-Coding RNAs as Epigenetic Regulators in Cancer.
    Tachiwana H; Saitoh N
    Curr Med Chem; 2021; 28(25):5098-5109. PubMed ID: 33588720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation.
    Chen C; Ding P; Yan W; Wang Z; Lan Y; Yan X; Li T; Han J
    Biochem Pharmacol; 2023 Aug; 214():115643. PubMed ID: 37315816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients.
    Toraih EA; Abdelghany AA; Abd El Fadeal NM; Al Ageeli E; Fawzy MS
    Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1897-1913. PubMed ID: 31327036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy.
    Wu Y; Jia K; Wu H; Sang A; Wang L; Shi L; Jiang K; Dong J
    Mol Med Rep; 2019 Feb; 19(2):851-860. PubMed ID: 30535492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
    Shao J; Zhang Y; Fan G; Xin Y; Yao Y
    BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy.
    Wang N; Ding L; Liu D; Zhang Q; Zheng G; Xia X; Xiong S
    Front Endocrinol (Lausanne); 2022; 13():918605. PubMed ID: 35957838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
    Lu J; Huang Y; Zhang X; Xu Y; Nie S
    Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation.
    Poltronieri P
    Explor Target Antitumor Ther; 2024; 5(4):841-876. PubMed ID: 39280246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.